Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
2009 AUG 3 ... "The cutaneous form of the disease is most common in the Old World. Pentavalent antimonials in the form of an injection represent the most widely used therapy for all clinical ...
2009 APR 13 ... Wurzburg, Germany, "Alternative drugs against leishmaniasis are desperately needed. Antimonials, the main chemotherapeutic tool, cause serious side effects and promote ...
2009 AUG 17 ... and viral load was 51,030 +/- 133,737/mm(3). Treatment consisted of pentavalent antimonials (67% of cases). Most (87%) patients recovered from VL infection: death occurred in I ...
2009 JUL 20 ... wrote F. Jeddi and colleagues. The researchers concluded: "Pentavalent antimonials should be definitively withdrawn in patients with hypereosinophilia > 1,000 ...
2009 MAY 4 ... outcome in peruvian patients with tegumentary leishmaniasis treated with pentavalent antimonials,' new data in leishmaniasis. According to a study from Geneva, Switzerland, "The ...
2009 MAY 4 ... of leishmania parasites in a skin smear preparation; he was treated satisfactorily with antimonials."
Ul and colleagues published their study in Dermatology Online ...
2009 AUG 17 ... inevitably fatal. For the last 70 years, the first line of defense has been pentavalent antimonials; however, increased resistance has brought amphotericin B to the forefront of treatment ...
2007 OCT 29 ... countries. The drugs of choice for the treatment of leishmaniasis are the pentavalent antimonials, which show renal and cardiac toxicity," researchers in Maringa, Brazil report.
...
2007 DEC 3 ... The researchers concluded: "In particular, the avoidance of the parenteral antimonials would greatly increase patient compliance and reduce treatment costs."
...
2008 SEP 22 ... arsenite-translocating ArsAB pump that is responsible for resistance to arsenicals and antimonials in Escherichia coli. ATPase activity is activated by either arsenite or antimonitc."
...
2008 NOV 24 ... AmB is employed. Importantly, cure rates exhibited by different drugs, including antimonials in areas where they are still in routine use, are similarly high (>= 95%) in ...
2008 APR 7 ... however, this is frequently overlooked or delayed in transplant patients. Pentavalent antimonials are the most commom form of treatment for VL, but have a high incidence of toxicity ...
2008 AUG 18 ... drugs are the first line of treatment against Leishmaniasis. Resistance to antimonials in Leishmania is proposed to be due to reduced uptake of trivalent antimony (SbIII) ...
2008 SEP 1 ... factors increase the cost of the treatment. The development of resistance to pentavalent antimonials in patients with visceral leishmaniasis in North Bihar, India, has added another ...
2008 MAY 19 ... 'Roles of trypanothione S-transferase and tryparedoxin peroxidase in resistance to antimonials,' is the subject of a report. "The clinical value of antimonial drugs, the mainstay ...
2008 DEC 29 ... have been the first-line therapeutic option for more than 50 years.
"But antimonials may cause acute pancreatitis and cardiac arrhythmia and can sometimes lead to death," ...
